This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cleland, S. J. Articles by Connell, J. M. C. Search for Related Content PubMed PubMed Citation Articles by Cleland, S. J. Articles by Connell, J. M. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes High Blood Pressure Hazardous Substances DB GLUCOSE NITRIC OXIDE Related Collections Endothelium/vascular type/nitric oxide

(Hypertension. 2000;35:507.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Insulin Action Is Associated With Endothelial Function in Hypertension and Type 2 Diabetes

Stephen J. Cleland; John R. Petrie; Michael Small; Henry L. Elliott; John M. C. Connell

From the Department of Medicine and Therapeutics, University of Glasgow, Glasgow, Scotland.

Correspondence to Dr Stephen J. Cleland, Department of Medicine and Therapeutics, University of Glasgow, Glasgow, Scotland, UK, G11 6NT. E-mail scleland{at}clinmed.gla.ac.uk

Abstract—A primary defect in the vascular action of insulin may be a key intermediate mechanism that links endothelial dysfunction with reduced insulin-mediated cellular glucose uptake in metabolic and cardiovascular disorders. The present study was designed to characterize more fully the relations between insulin action and endothelial function in male patients with essential hypertension (H, n=9) or type 2 diabetes (D, n=9) along with healthy control subjects (C) matched for age, body mass index, and lipid profile. They attended for measurement of whole-body insulin sensitivity (MCR) by the hyperinsulinemic clamp technique (day 1) and forearm vasoreactivity in response to intra-arterial infusions of insulin/glucose (day 2) and N^G-monomethyl-L-arginine (L-NMMA) and norepinephrine (day 3) by bilateral venous-occlusion plethysmography. Results expressed as mean±SE MCR (mL/kg per minute) were 7.22±0.99 (C), 6.32±0.78 (H), and 5.06±0.53 (D). Insulin/glucose-mediated vasodilation (IGMV) was 17.1±5.6% (C), 17.2±5.5% (H), and 12.3±6.4% (D). L-NMMA vasoconstriction (LNV) was 37.9±5.1% (C), 37.5±2.3% (H), and 33.6±2.8% (D). There were no significant differences among groups for these parameters. Pooled correlation analyses revealed associations between MCR and IGMV (r=0.46, P<0.05), MCR and LNV (r=0.44, P<0.05), and IGMV and LNV (r=0.52, P<0.01). This study supports functional coupling between insulin action (both metabolic and vascular) and basal endothelial nitric oxide production in humans.

Key Words: insulin • endothelium • nitric oxide • hyperinsulinism • hypertension, essential • diabetes mellitus

This article has been cited by other articles:

				M. T. McCormick, K. W. Muir, C. S. Gray, and M. R. Walters Management of Hyperglycemia in Acute Stroke: How, When, and for Whom? Stroke, July 1, 2008; 39(7): 2177 - 2185. [Full Text] [PDF]

				D. Heutling, H. Schulz, I. Nickel, J. Kleinstein, P. Kaltwasser, S. Westphal, F. Mittermayer, M. Wolzt, K. Krzyzanowska, H. Randeva, et al. Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 82 - 90. [Abstract] [Full Text] [PDF]

				S. J Hamilton, G. T Chew, and G. F Watts Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 89 - 102. [Abstract] [PDF]

				L. M. Thorn, C. Forsblom, J. Fagerudd, M. C. Thomas, K. Pettersson-Fernholm, M. Saraheimo, J. Waden, M. Ronnback, M. Rosengard-Barlund, C.-G. a. Bjorkesten, et al. Metabolic Syndrome in Type 1 Diabetes: Association with diabetic nephropathy and glycemic control (the FinnDiane study) Diabetes Care, August 1, 2005; 28(8): 2019 - 2024. [Abstract] [Full Text] [PDF]

				S Jadhav, J Petrie, W Ferrell, S Cobbe, and N Sattar Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart, December 1, 2004; 90(12): 1379 - 1383. [Abstract] [Full Text] [PDF]

				M. L. Cruz, M. J. Weigensberg, T. T.-K. Huang, G. Ball, G. Q. Shaibi, and M. I. Goran The Metabolic Syndrome in Overweight Hispanic Youth and the Role of Insulin Sensitivity J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 108 - 113. [Abstract] [Full Text] [PDF]

				K. E. Watson, A. L. Peters Harmel, and G. Matson Atherosclerosis in Type 2 Diabetes Mellitus: The Role of Insulin Resistance Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 253 - 260. [Abstract] [PDF]

				C. G. Perry, A. Spiers, S. J. Cleland, G. D. O. Lowe, J. R. Petrie, and J. M. C. Connell Glucocorticoids and Insulin Sensitivity: Dissociation of Insulin's Metabolic and Vascular Actions J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6008 - 6014. [Abstract] [Full Text] [PDF]

				D.-H. Lee, D. R. Jacobs Jr, M. Gross, C. I. Kiefe, J. Roseman, C. E. Lewis, and M. Steffes {gamma}-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study Clin. Chem., August 1, 2003; 49(8): 1358 - 1366. [Abstract] [Full Text] [PDF]

				C. Torp-Pedersen, C. Rask-Madsen, I. Gustafsson, F. Gustafsson, and L. Kober Diabetes mellitus and cardiovascular risk: just another risk factor? Eur. Heart J. Suppl., August 1, 2003; 5(suppl_F): F26 - F32. [Abstract] [PDF]

				I. P. Salt, V. A. Morrow, F. M. Brandie, J. M. C. Connell, and J. R. Petrie High Glucose Inhibits Insulin-stimulated Nitric Oxide Production without Reducing Endothelial Nitric-oxide Synthase Ser1177 Phosphorylation in Human Aortic Endothelial Cells J. Biol. Chem., May 23, 2003; 278(21): 18791 - 18797. [Abstract] [Full Text] [PDF]

				E. C. Eringa, C. D.A. Stehouwer, T. Merlijn, N. Westerhof, and P. Sipkema Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles Cardiovasc Res, December 1, 2002; 56(3): 464 - 471. [Abstract] [Full Text] [PDF]

				B. A. Kingwell, M. Formosa, M. Muhlmann, S. J. Bradley, and G. K. McConell Nitric Oxide Synthase Inhibition Reduces Glucose Uptake During Exercise in Individuals With Type 2 Diabetes More Than in Control Subjects Diabetes, August 1, 2002; 51(8): 2572 - 2580. [Abstract] [Full Text] [PDF]

				M. L. Cruz, T. T-K. Huang, M. S. Johnson, B. A. Gower, and M. I. Goran Insulin Sensitivity and Blood Pressure in Black and White Children Hypertension, July 1, 2002; 40(1): 18 - 22. [Abstract] [Full Text] [PDF]

				C. J. G. Kelly, A. Speirs, G. W. Gould, J. R. Petrie, H. Lyall, and J. M. C. Connell Altered Vascular Function in Young Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 742 - 746. [Abstract] [Full Text] [PDF]

				A. M Storey, C. J Perry, and J. R Petrie Review: Endothelial dysfunction in type 2 diabetes The British Journal of Diabetes & Vascular Disease, August 1, 2001; 1(1): 22 - 27. [Abstract] [PDF]